Innate Pharma Stock
Innate Pharma Stock
There is an upward development for Innate Pharma compared to yesterday, with an increase of €0.028 (2.510%).
Our community identified positive and negative aspects for Innate Pharma stock for the coming years. 1 users see the criterium "Worthwhile Investment for the next years" as a plus for the Innate Pharma stock. On the other hand our users think that "Worthwhile Investment for the next years" could be a problem in the future.
Pros and Cons of Innate Pharma in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Innate Pharma vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Innate Pharma | 2.510% | -19.741% | -1.937% | -35.607% | -27.190% | -57.883% | -67.673% |
| Nanobiotix | 1.570% | -1.341% | 6.514% | 893.250% | 46.387% | 1020.641% | 114.089% |
| Poxel S.A. | -1.310% | 1.538% | 13.305% | -38.960% | 10.460% | -60.947% | -95.885% |
| Adocia | -0.040% | -9.494% | -5.255% | 19.282% | -29.515% | 66.440% | -52.140% |
